Qorvo Biotechnologies Awarded $4.1 Million National Institutes of Health Contract for SARS-CoV-2/ Flu Combo and Antigen Pooling

Source: Nasdaq GlobeNewswire / 07 Feb 2022 08:00:00   America/New_York